• en
    • he
    • ru
Home » Insights » Transactions » V-WAVE

V-WAVE

29.04.2018 | PE Financing

Hi-Tech Department represented V-Wave Ltd. in a $70M Financing Round to Support Pivotal Study of its Heart Failure Therapy activity

Attorneys Itamar Mei-Zahav, Tamir Chagal and Ohad Gurfinkel from ZAG-S&W Tel-Aviv Offices, represented V-Wave Ltd. through the various stages of the investment process and continue to provide ongoing legal services to support V-Wave Ltd.’s corporate and clinical activity.

Wave Ltd. is developing a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF) and Pulmonary Arterial Hypertension (PAH).

Recent Activity

All Media
This Media article belongs to the category: News The article was published in the 05th April 2020. | IVC

Article title: IVC Report Q1/2020 -Israeli High-Tech Company Capital Raising
This Media article belongs to the category: Events The article was published in the 12th February 2020. | Jerusalem Post

Article title: MeetUp on “How to Due (Diligence) it Right”
This Media article belongs to the category: News The article was published in the 12th January 2020. | IVC

Article title: IVC Report Q4/2019 -Growth of Hi-Tech Companies
This Media article belongs to the category: Transactions The article was published in the 03rd March 2017. | IPO

Article title: Therapix Biosciences
This Media article belongs to the category: Transactions The article was published in the 12th November 2016. | NASDAQ

Article title: Rosetta Genomics Ltd.
This Media article belongs to the category: Transactions The article was published in the 24th July 2015. | NASDAQ

Article title: Pluristem Therapeutics Inc.